0 CHECKOUT

PRODUCT FILTERS

REGION

5
4
4
4
4

COUNTRY

4
1
1

CATEGORIES

  • 10
  • 4
  • 3
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1

PRICE

4
8
15
22

PUBLISHED

2
2
3
22

PRODUCT TYPE

19
2
1

Search for: "Sandoz Generics Company Intelligence Report"

Sandoz International GmbH - Strategy and SWOT Report

Sandoz International GmbH - Strategy and SWOT Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service...

Published:  November 2015
Price:  From

Generic Growth Strategies - Market Driven by Impending Patent Cliff, Declining R&D Productivity and Government Initiatives to Reduce Healthcare Costs

Generic Growth Strategies - Market Driven by Impending Patent Cliff, Declining R&D Productivity and Government Initiatives to Reduce Healthcare Costs Summary GBI Research, the leading business intelligence...

Published:  December 2012
Price:  From

Generics in Cardiovascular Diseases Market to 2018 - Loss of Lipitor Market Exclusivities and Impending Patent Expirations of Plavix to Drive Generic Substitution

GBI Research, the leading business intelligence provider, has released its latest research “Generics in Cardiovascular Diseases Market to 2018 - Loss of Lipitor Market Exclusivities and Impending Patent...

Published:  May 2012
Price:  From

The Pharmaceutical Market: Germany

These highly regarded world pharmaceutical market reports have been redesigned to provide enhanced strategic intelligence in a user-friendly format. Each report provides in-depth information, setting...

Published:  May 2012
Price:  From

Global Pharmaceutical Logistics 2012

Global pharma supply chains are undergoing a transformation Structural changes in the pharmaceutical manufacturing industry are set to create significant opportunities for logistics service providers...

Published:  December 2011
Price:  From

Global Biosimilars Industry 2015

Biosimilar is a term used to describe officially approved subsequent versions of innovator biopharmaceutical products made by a different sponsor following patent and exclusivity expiry on the innovator...

Published:  February 2015
Price:  From

Competitor Analysis: Human Growth Hormone (hGH)

The Competitive Intelligence Report Human Growth Hormone (hGH) as of April 2013 provides a competitor analysis in the development pipeline of biosimilar versions of somatropin and next generation biobetter/biosuperior...

Published:  April 2013
Price:  From

Escitalopram - Patent, Extension and Data Exclusivity Expiry Snapshot (51 countries)

Need fast access to comprehensive SPC, data exclusivity, and litigation intelligence that’s simple to access and use? Already used by big pharma, biologics manufacturers and their law firms, Patent,...

Published:  May 2016
Price: 

Escitalopram - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

Need fast access to comprehensive SPC, data exclusivity, and litigation intelligence that’s simple to access and use? Already used by big pharma, biologics manufacturers and their law firms, Patent,...

Published:  May 2016
Price: 

The Pharmaceutical Market: USA

These highly regarded world pharmaceutical market reports have been redesigned to provide enhanced strategic intelligence in a user-friendly format. Each report provides in-depth information, setting...

Published:  May 2012
Price:  From

Competitor Analysis: G-CSF and GM-CSF

he present Competitive Intelligence Report about G-CSF and GM-CSF product portfolios and R&D pipelines provides a competitor evaluation in the field of G-CSF & GM-CSF branded products in regulated markets...

Published:  April 2013
Price:  From

The Pharmaceutical Market: Brazil

This in-depth pharmaceutical market report is ideal for executives wanting to understand the key drivers in pharmaceutical markets and have access to a wealth of statistical data. Each report opens...

Published:  May 2012
Price:  From

Biosimilars in Developed Countries - Launch of Biosimilar mAbs in Europe and New Regulatory Pathways in the US to Spur Market Growth

GBI Research, the leading business intelligence provider, has released its latest report, “Biosimilars in Developed Countries - Launch of Biosimilar mAbs in Europe and New Regulatory Pathways in the...

Published:  July 2012
Price:  From

Biosimilars Approval Pathways in the US and Europe - Development and Approval of Biosimilar mABs May Face Tough Regulatory Environment

Biosimilars Approval Pathways in the US and Europe - Development and Approval of Biosimilar mABs May Face Tough Regulatory Environment Summary GBI Research, the leading business intelligence provider,...

Published:  April 2011
Price:  From

Competitor Analysis: Erythropoietin (EPO)

The Competitive Intelligence Report Erythropoietin (EPO) & Erythropoiesis Stimulating Agents (ESA) as of January 2011 in its 5th edition provides information on existing first and second generation...

Published:  January 2011
Price:  From

The Outlook for Pharmaceuticals in Western Europe

Market growth in the mature markets of Western Europe is assured over the coming years by the health needs of ageing populations, and will be driven by investment in innovative medicines, particularly...

Published:  February 2012
Price:  From

Novartis AG (NOVN) - Product Pipeline Analysis, 2014 Update

Summary Novartis AG (Novartis) is a healthcare solutions company. It undertakes the discovery, development and commercialization of a wide range of novel and generic products across various therapeutic...

Published:  May 2014
Price:  From

Alcon Medical Device Company Intelligence Report

Medical Device Company Intelligence Reports provide a full review of the company's activities, from its origins to its latest corporate activity, including mergers and acquisitions, agreements, divestitures,...

Published:  January 2013
Price:  From

Global Biosimilars Industry

Biosimilar is a term used to describe officially approved subsequent versions of innovator biopharmaceutical products made by a different sponsor following patent and exclusivity expiry on the innovator...

Published:  October 2012
Price:  From

Bone and Joint Infection Market to 2016 - Medical Imaging and PCR Methods to Facilitate Early Diagnosis and Treatment

Bone and Joint Infection Market to 2016 - Medical Imaging and PCR Methods to Facilitate Early Diagnosis and Treatment Summary GBI Research, the leading business intelligence provider, has released its...

Published:  February 2011
Price:  From
Loading Indicator

Our Clients

  • Goodyear Tire & Rubber Company
  • GlaxoSmithKline PLC
  • Hilton Worldwide
  • Hewlett-Packard Company
  • Accenture PLC
  • Qualcomm Incorporated
  • UBS AG